Teva Recalls 300,000 Blood Pressure Patch Cartons Due to Unapproved Ingredient

Teva Pharmaceuticals has issued a Class II recall for approximately 300,000 cartons of blood pressure patches containing an unapproved ingredient. The affected patches were manufactured by Actavis for Teva and come in three different dosage strengths. Patients using these patches are strongly advised not to discontinue use without first consulting their healthcare provider. The recall was prompted by the discovery of an ingredient not approved by regulatory authorities in the medication. This action represents a significant pharmaceutical safety measure affecting a substantial volume of medication. The recall notice emphasizes the importance of medical guidance before altering treatment regimens. Specific details about the unapproved ingredient were not disclosed in the initial announcement. The recall covers all distributed units of the affected product batches.